Antiviral drugs

General description Leukocyte interferon is produced predominantly by B lymphocytes. Immune interferon (IFN-gamma: MIM 147570) is produced by mitogen- or antigen-stimulated T lymphocytes.

Immunogen IFNA6 (NP_066282.1, 1 a.

Anti-IFNA6 interferon, alpha 6, 100ul UN 1687 6.1 PG2

Anti-IFNA6 interferon, alpha 6, 25ul UN 1687 6.1 PG2

General description Interferon alpha/beta receptor 1 (IFNAR-1) is a single-pass type I membrane protein containing three fibronectin type-III domains and is a member of the type II cytokine receptor family. IFNAR-1 serves as an interferon receptor

Anti-IFNAR1 interferon (alpha, beta and omega) receptor 1, 1

Anti-IFNAR1 interferon (alpha, beta and omega) receptor 1, 1

Anti-IFNAR1 interferon (alpha, beta and omega) receptor 1, 2

Anti-IFNAR1 interferon (alpha, beta and omega) receptor 1, 2

General description The protein encoded by this gene is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulates Janus protein kinases, which in turn

Immunogen IFNB1 (NP_002167, 1 a.a.

General description IFNB1 has antiviral, antibacterial and anticancer activities. Immunogen Synthetic peptide directed towards the middle region of human IFNB1 Sequence Synthetic peptide located within the following region: